Article Sidebar

Submitted
3 March 2023
Accepted
19 June 2023
Published
30 June 2023
Download
PDF (Bahasa Indonesia)
Statistic
Read Counter : 665 Download : 647

Main Article Content

Abstract

DM Type 2 is a chronic disease and Indonesia is ranked 7th in the world. This situation causes health burden, both economically and disability. The Disease Management Program was developed to control patient health status and control costs. Prolanis is a form of disease management program organized by BPJS Kesehatan. The purpose of this study was to analize impact of  Type 2 DM Prolanis on controlling blood glucose levels in patients. This is a quantitative study with a crosssectional design by comparing Type 2 DM patients who participate in Type 2 DM Prolanis with those who do not take part in the program at 15 target FKTPs in  the region of  Pematangsiantar branch of BPJS Kesehatan. Using secondary data which was conducted retrospectively in 2021 involving 717 respondents.The majority of respondents were participants I Type 2 DM Prolanis (70,29%), aged 56 years and over,  female (57,34%), high school educated (39,47%), coming from the BP segment (retirement) (40o.44%). Have followed Type 2 DM Prolanis for more than 6 months (more than 85 % of respondents), and actively visited FKTPs for more than 3 times during the period of January to December 2021.

Keywords

DM Tipe 2 Disease Managemen Program Prolanis Type 2 DM Disease Management Program Chronic Disease Management Program

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Author Biography

Firdauz Hafidz As Shidieq, Dosen FK KMK Universitas Gajah Mada

Bapak dr. Firdauz Hafidz as Shidieq, MPH, AAK, PhD adalah dosen pada Fakultas Kedokteran Kesehatan Masyarakat dan Keperawatan Universitas Gajah Mada di Yogjakarta Indonesia.

How to Cite
Marbun, K. C., & As Shidieq, F. H. (2023). Pengaruh Keikutsertaan Program Pengelolaan Penyakit Kronis Terhadap Kendali Glukosa Darah Pasien Diabetes Melitus Tipe 2 Di Cabang Pematangsiantar : Pengaruh Keikutsertaan Program Pengelolaan Penyakit Kronis Terhadap Kendali Glukosa Darah Pasien Diabetes Melitus Tipe 2 Di Cabang Pematangsiantar . Jurnal Jaminan Kesehatan Nasional, 3(1). https://doi.org/10.53756/jjkn.v3i1.139
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Ackermann, R. T., Marrero, D. G., Hicks, K. A., Hoerger, T. J., Sorensen, S., Zhang, P., Engelgau, M. M., Ratner, R. E., & Herman, W. H. (2006). An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetes. Diabetes Care, 29(6), 1237–1241. https://doi.org/10.2337/dc05-1709
  2. Aryani, A. D., Kurdi, F. N., & Soebyakto, B. (2016). Cost Effectiveness Analysis (CEA) Program Pengelolaan Penyakit Kronis (PROLANIS) Diabetes Melitus Tipe 2 Peserta JKN di Kota Serang Banten. JURNAL KEDOKTERAN DAN KESEHATAN, 3(3), 146–154.
  3. Diabetes Association, A. (2010). Diagnosis and classification of diabetes mellitus. Diabetes Care, 33(SUPPL. 1). https://doi.org/10.2337/dc10-S062
  4. Freeman, R., Lybecker, K. M., & Wayne Taylor, D. (2011). The Effectiveness of Disease Management Programs in the Medicaid Population. The Cameron Institute, 1–44.
  5. Hamzah, A., & Sulistiadi, W. (2017). 46 Implementasi Kebijakan Rujuk Balik Diabetes Melitus Hamzah & Sulistiadi. Jurnal Ekonomi Kesehatan Indonesia, 1, 146–151.
  6. Hosseinzadeh, S., Khatirnamani, Z., Bakhshi, E., Heidari, A., & Naghipour, A. (2022). Assessing related factors to fasting blood sugar and glycosylated hemoglobin in patients with type 2 diabetes simultaneously by a multivariate longitudinal marginal model. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-19241-1
  7. Idris, F. (2014). Pengintegrasian Program Preventif Penyakit Diabetes Melitus Tipe 2 PT Askes (Persero) ke Badan Penyelenggara Jaminan Sosial Kesehatan (BPJS Kesehatan). J Indon Med Assoc, 64, 115–136.
  8. Kementrian Kesehatan Republik Indonesia. (2013). Permenkes RI No.71 (No. 71). Kementerian Kesehatan Republik Indonesia.
  9. Kementrian Kesehatan Republik Indonesia. (2018). Hasil Utama RISKESDAS 2018.
  10. Khunti, K., Gray, L. J., Skinner, T., Carey, M. E., Realf, K., Dallosso, H., Fisher, H., Campbell, M., Heller, S., & Davies, M. J. (2012). Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: Three year follow-up of a cluster randomised controlled trial in primary care. BMJ (Online), 344(7860), 1–12. https://doi.org/10.1136/bmj.e2333
  11. Mwavua, S. M., Ndungu, E. K., Mutai, K. K., & Joshi, M. D. (2016). A comparative study of the quality of care and glycemic control among ambulatory type 2 diabetes mellitus clients, at a Tertiary Referral Hospital and a Regional Hospital in Central Kenya. BMC Research Notes, 9(1). https://doi.org/10.1186/s13104-015-1826-0
  12. PerDir BPJS Kesehatan, Peraturan Direktur Badan Penyelenggara Jaminan Sosial Kesehatan (2019).
  13. Riaz, F., Al Shaikh, A., Anjum, Q., Mudawi Alqahtani, Y., & Shahid, S. (2021). Factors related to the uncontrolled fasting blood sugar among type 2 diabetic patients attending primary health care center, Abha city, Saudi Arabia. International Journal of Clinical Practice, 75(7). https://doi.org/10.1111/ijcp.14168
  14. Schäfer, I., Küver, C., Gedrose, B., Hoffmann, F., Ru-Thiel, B., Brose, H. P., Van Den Bussche, H., & Kaduszkiewicz, H. (2010). The disease management program for type 2 diabetes in Germany enhances process quality of diabetes care - A follow-up survey of patient’s experiences. BMC Health Services Research, 10. https://doi.org/10.1186/1472-6963-10-55
  15. Sidorov, J., Shull, R., Tomcavage, J., Girolami, S., Lawton, N., & Harris, R. (2002). Does Diabetes Disease Management Save Money and Improve Outcomes? Diabetes Care, 25(4), 684–689.